Harrier deal

HARE's agreement in principal to merge with privately held American Diagnostica Inc. has been terminated because American Diagnostica's shareholders anticipated adverse consequences from the merger, HARE said.

HARE (Los Angeles) and American Diagnostica will continue their 1993 agreement to develop synthetic drugs using HARE's glycosylation processes to modify and enhance the physical and biological properties of existing pharmaceuticals. ...